-
Benitec Reports Encouraging Early Clinical Results for AAV9 Gene Therapy BB-301 in OPMD
Mar 09 2026 -
Precision BioSciences’ AAV Gene Editing Therapy PBGENE-DMD Receives FDA Fast Track Designation
Mar 09 2026 -
Sangamo Advances AAV Gene Therapy ST-920 Toward FDA Accelerated Approval for Fabry Disease
Mar 09 2026 -
AAV-Mediated Parkin Gene Therapy Shows Promising Rescue of Dopaminergic Neurons in Parkinson’s Disease Models
Mar 05 2026 -
Passage Bio Advances AAV Gene Therapy Program for Frontotemporal Dementia and Expands Neurodegenerative Pipeline
Mar 04 2026 -
FDA Details Reasons for Rejecting Regenxbio’s AAV Gene Therapy RGX-121 for Hunter Syndrome
Mar 04 2026 -
Bayer Prioritizes AAV Gene Therapy AB-1009 for Pompe Disease
Mar 04 2026 -
Cure Rare Disease and LGMD2L Foundation Announce Gene Therapy Partnership for ANO5-Related Disease
Mar 03 2026 -
New HIT Receptor Technology Enables CAR-T Cells to Detect Low-Antigen Tumor Cells in Solid Cancers
Mar 03 2026